Watch our free webinar to learn about some of the regulatory challenges and market entry options as you consider your strategy for the Japan market.
Different Market Entry Options Available to UK Life Science and Pharma Companies in Japan
Background to the Webinar
The revised law for regulating pharmaceuticals, medical devices and regenerative medicine products – the “Pharmaceutical and Medical Devices Act” – was enforced in November 2014 and Japan has reduced regulatory timelines and introduced a number of favourable initiatives for fast-tracking and premium price acquisition. Now may be the best time ever to enter the Japanese market. However, new entrants should be aware of the regulatory challenges and market entry options to consider their strategy for the Japan market.
This content has been restricted to logged in users only. Please login to view this content.
